FCM
CELG

Farallon Capital Management’s Celgene Corp CELG Stock Holding History

Farallon Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,569,730
Closed -$1.55B – 132
2019
Q3 		$1.55B Buy
15,569,730
+124,730
+0.8% +$11.9M 11.68% 1
2019
Q2 		$1.43B Buy
15,445,000
+7,015,000
+83% +$666M 9.29% 2
2019
Q1 		$795M Buy
+8,430,000
New +$737M 5.98% 3

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Farallon Capital Management's CELG Position: Q4 2019 in Review

Farallon Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,569,730 shares — an estimated $1.55B sold.

Farallon Capital Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $1.55B in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Farallon Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Farallon Capital Management sold 15,569,730 Celgene Corp shares in Q4 2019, an estimated $1.55B.
  • Farallon Capital Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Farallon Capital Management's Celgene Corp position peaked at $1.55B in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.